drugset / Trial / NCT07569315

Successive Doses of GnRH Agonist Versus Single Dose of GnRH Agonist to Trigger Ovulation in Hyper-responders

NCT07569315

Phase 2 Not yet recruiting 190 enrolled Bedaya Hospital
RandomizedParallel-groupSingle-blindTreatment

Summary

The aim of this randomized controlled study is to compare the efficacy of three successive doses of a GnRH agonist ( administered 36 , 24 and 12 hours before oocyte retrieval ) with a single dose of a GnRH agonist ( administered 36 hours before oocyte retrieval ) in triggering ovulation in hyper-responders

Timeline

Start
2026-06-01
Primary completion
2027-12-01
Completion
2028-04-01

Drugs

EvaluationDrugModalityDoseRoute
Subject Triptorelin Other / unclassified 0.1 mg Subcutaneous
Subject Triptorelin Other / unclassified 0.2 mg Subcutaneous

Indications